Kuano

PITCH

We are de-risking and accelerating drug discovery by combining quantum and AI. As an AI/Biotech hybrid, we are using a novel approach to generate better enzyme inhibitors. Our uniquely positioned, proprietary, discovery platform addresses key liabilities such as specificity, potency, and resistance.

Based in

London

Created in

> Website

LATEST INVESTMENT

#DeepTech 07.2021

£1M

ACF Investors, o2h Ventures & Angels